Characteristics | Number of patients (%)a | Number of deaths (%)b |
---|---|---|
Sex | ||
Female | 500 (48.8%) | 21 (4.2%) |
Male | 524 (51.2%) | 99 (18.9%) |
Age (years) | ||
15 – 32 years | 338 (33.0%) | 27 (8.0%) |
33 – 40 years | 401 (39.2%) | 52 (13.0%) |
>40 years | 285 (27.8%) | 41 (14.4%) |
Education | ||
Illiterate | 650 (73.5%) | 69 (10.6%) |
Literate | 234 (26.5%) | 35 (15.0%) |
Missing data | 140 (13.6%) | |
Baseline performance scale | ||
Normal | 732 (73.1%) | 45 (6.1%) |
Bedridden <50% | 182 (18.2%) | 44 (24.2%) |
Bedridden >50% | 87 (8.7%) | 28 (32.2%) |
Missing data | 23 (2.2%) | |
Baseline bodyweight ( kg) | ||
< 45 Kg | 484 (49.1%) | 58 (12.0%) |
45 – 60 Kg | 479 (48.6%) | 49 (10.2%) |
>60 Kg | 23 (2.3%) | 2 (8.7%) |
Missing data | 38 (3.7%) | |
Baseline WHO clinical stage | ||
Stage I or II | 320 (34.2%) | 10 (3.1%) |
Stage III | 455 (48.6%) | 63 (13.8%) |
Stage IV | 161 (17.2%) | 41 (25.5%) |
Missing data | 88 (8.6%) | |
Baseline CD4 count (cells/ mm 3 ) | ||
≤ 50 cells/mm3 | 127 (13.6%) | 19 (15.0%) |
51- 200 cells/mm3 | 533 (57.1%) | 69 (13.0%) |
>200 cells/mm3 | 274 (29.3%) | 14 (5.1%) |
Missing data | 90 (8.8%) | |
Drug toxicity/ side effects | ||
No | 788 (80.9%) | 83 (10.5%) |
Yes | 186 (19.1%) | 31 (16.7%) |
Missing data | 50 (4.9%) | |
Active TB during treatment | ||
No | 856 (83.6%) | 89 (10.4%) |
Yes | 168 (16.4%) | 31 (18.5%) |
Baseline ART regimen # | ||
d4T/3TC/NVP | 151 (14.8%) | 26 (17.2%) |
d4T/3TC/EFV | 44 (4.3%) | 7 (16.0%) |
ZDV/3TC/NVP | 702 (69.0%) | 64 (9.1%) |
ZDV/3TC/EFV | 118 (11.6%) | 20 (17.0%) |
TDF/3TC/EFV | 3 (0.3%) | 0 |
Missing data | 6 (0.6%) | |
Baseline ART regimen change | ||
No | 760 (74.2%) | 78 (10.3%) |
Yes | 264 (25.8%) | 42 (16.0%) |
ART centre/ sub centre | ||
Seti Zonal hospital | 590 (57.6%) | 51 (8.6%) |
Kanchanpur Zonal hospital | 70 (6.8%) | 13 (18.6%) |
Achham District hospital | 176 (17.2%) | 24 (13.6%) |
Doti district hospital | 176 (17.2%) | 32 (18.2%) |
Tikapur hospital | 12 (1.2%) | 0 |